Mircea, a former miner in his fifties, spent the last four years of his life succumbing to Extensively Drug Resistant Tuberculosis (XDR-TB) at the Pines Tuberculosis Sanatorium, which is located high on a mountain. After seven years with this otherwise curable illness, his family wanted ...

Three quarters of those using England’s free self-sampling service are men who have sex with men, with the service particularly popular among younger men and men who have not recently tested, Luis Guerra of Public Health England told a Public Health England seminar last week. While ...

Strong adherence to antiretroviral therapy suppresses viral load to undetectable levels within people living with HIV, greatly reducing the risk of transmitting the virus to others. When large proportions of people living with HIV within a community are on treatment, it has been shown to ...

If sufficient money is available to pay for direct-acting antivirals (DAAs), the US Veterans Affairs (VA) could cure the majority of veterans under its care of hepatitis C within three years, and has already shown it has the capacity to initiate almost 7000 people on ...

A triple regimen of grazoprevir/elbasvir (Zepatier) plus sofosbuvir (Sovaldi) without ribavirin cured 96% of previously untreated and 97% of treatment-experienced people with hepatitis C virus (HCV) genotype 3 and liver cirrhosis, matching rates seen in easier-to-treat patient groups, according to results from the C-ISLE study ...

Direct-acting antiviral treatment is curing people of hepatitis C in real-world clinical practice at similar rates to those seen in clinical trials, and there do not seem to be major differences between drug regimens, according to results of a large population study presented at the ...

The EU Civil Society Forum on HIV sent the following statement to the European Commission ahead of the Board of the Global Fund to fight AIDS, Tuberculosis and Malaria next week which will decide on how much money countries around the world will receive to ...

Scientists have developed a type of HIV test on a USB stick. The device, created by scientists at Imperial College London and DNA Electronics, uses a drop of blood to detect HIV, and then creates an electrical signal that can be read by a computer, laptop ...

The Liver Meeting is organized by the American Association for the Study of Liver Diseases and is being held in Boston, US on November 11-15. New combination therapy could cure hepatitis C with only 4 weeks of treatment Is there an increased risk of cancer ...

Cabotegravir levels still measurable a year after last injection in one in six participants A study presented at last month’s HIV Research for Prevention (HIVR4P) conference in Chicago shows that in a minority of subjects who were given an experimental injectable drug as HIV pre-exposure prophylaxis ...

The combination of ledipasvir and sofosbuvir was effective and well-tolerated among patients with acute hepatitis C genotype 1, according to researchers in Germany. Researchers wrote that short-duration HCV treatments could prevent the spread of the virus, and could be less expensive compared with the cost of ...

Theratechnologies announces results from the last pivotal Phase III trial of HIV long acting biologic (LAB) investigational antiretroviral ibalizumab Ibalizumab maintains significant reduction of viral load in patients with multi-drug resistant HIV-1 over 24 weeks Results from the study support the regulatory submission of the BLA to ...

Eight weeks of treatment with AbbVie’s investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P) achieved high SVR rates across all major genotypes of chronic hepatitis C 97.5 percent of chronic HCV infected patients without cirrhosis and new to treatment across all major genotypes (GT1-6) achieved SVR12 with 8 ...